STAT

Opinion: Cure ‘futures’ offer a way to pay for million-dollar medicines

Effective new drugs can make the world a better place — unless they aren’t accessible because those making the breakthroughs charge an enormous price to get a decent profit because they can, or because their investors demand it.

People who create viable businesses and their investors have a right to earn a return on the resources they expend to solve a problem, including finding cures for previously incurable diseases. But that is turning out to be problematic when it comes to new medicines, especially those with million-dollar price tags.

A recent focused on a newly approved leukemia treatment with a high success rate. The total treatment cost

You're reading a preview, sign up to read more.

More from STAT

STAT3 min read
Opinion: CBO Estimate On Pelosi Drug Bill Misses Its Long-term Impact On Health
The CBO estimate on Speaker Nancy Pelosi's drug pricing bill misses its long-term impact on health.
STAT5 min readScience
Opinion: Using CRISPR To Edit Eggs, Sperm, Or Embryos Does Not Save Lives
The real value of using CRISPR on eggs, sperm, or embryos accrues not to the individual who is created but to the people who choose to use it to create…
STAT4 min readSociety
An ‘Unprecedented’ Analysis Underlines Profound Failure To Study African Genomes
It has become the geneticist’s version of, “What, me not inclusive? But I have a black friend!” In the case of modern studies of DNA, researchers called to task for studying mainly European populations often defend themselves by pointing out that the